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doi:10.1016/j.ejvs.2011.03.027Abstract Introduction: Computed Tomography Angiography (CTA) is considered the gold
standard imaging technique for surveillance following endovascular aneurysm repair (EVAR).
Limitations of CTA include cost, risk of contrast nephropathy and radiation exposure. A modi-
fied surveillance protocol involving annual duplex ultrasound (DUS) and abdominal radiography
(AXR) was introduced, with CTA performed only if abnormalities were identified or DUS was
undiagnostic.
Methods: Prospective records were maintained on patients undergoing infra-renal EVAR at
a UK, tertiary referral centre. All patients enrolled with at least one-year follow-up were re-
viewed. Primary outcomes identified were aneurysm rupture and aneurysm-related complica-
tions. Secondary outcomes included number of CTAs avoided and cost.
Results: Median follow-up was 36 months (range 12e57) for 194 patients. The total number of
sets of surveillance imaging was 412 of which 70 (17%) required CTA. Abnormalities were found
in 30 patients, 18 confirmed by CTA. Eleven patients required secondary intervention, three
initially identified by AXR, three by DUS, three by both DUS and AXR, and two by CTA following
undiagnostic DUS. No patient presented with rupture or aneurysm-related complications not
identified by modified surveillance. Mean annual savings were V223.
Conclusion: EVAR surveillance based on DUS and AXR is feasible and safe. The complimentary
nature of AXR and DUS is demonstrated.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.education questions on this paper, please go to www.vasculareducation.com and click on ‘CME’
17063447; fax: þ44 151 7065638.
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Surveillance following endovascular aneurysm repair (EVAR)
is intended to identify features that potentially threaten
stent-graft durability.1,2 Computed tomography angiog-
raphy (CTA) remains the most utilised modality of surveil-
lance imaging.3 Concerns associated with CTA include the
risk of carcinogenesis from repeated exposure to ionising
radiation3,4 and the risk of contrast-induced nephropathy.3
Furthermore, surveillance imaging is a significant contrib-
utor to the overall cost of EVAR.5
In order to minimise the drawbacks of CTA, alternative
surveillance modalities such as duplex ultrasound (DUS) and
plain radiography are being increasingly employed. Duplex
sonography is able to determine aneurysm size, identify
and characterise endoleak and to visualise flow that indi-
cates adverse structural issues such as limb kinking. Plain
radiography performed according to protocol can demon-
strate stent-graft migration and structural disintegration. A
combination of DUS and AXR therefore has the potential to
reveal most of the information sought by surveillance
imaging.
Our institution has modified our post-EVAR surveillance
protocol to make optimal use of DUS and AXR in surveillance
and consequently reduce CTA. The purpose of this study
was to assess the efficacy of a modified post-EVAR surveil-
lance protocol based primarily on serial DUS and AXR.Methods
A retrospective review of a prospectively maintained data-
base of all patients undergoing elective standard EVAR at
a large tertiary referral centre was performed. Patients who
had their primary EVAR after 1st Aug 2005 and have had at
least 12 months follow-up data were included. Those with
incomplete follow-up were included if at least one set of
imaging was documented. Patients who were followed up at
other units were excluded, as were those who had advanced
stent-grafts, such as fenestrated, branched and iliac bifur-
cated devices as these all have CT-based surveillance.
Demographic data were recorded for each patient. The
primary outcome measure was aneurysm rupture.
Secondary outcomes were the requirement for secondary
intervention and the number of CTA avoided, from which
radiation dose reduction and cost savings were calculated.Table 1 Modified EVAR surveillance protocol.
Before discharge from hospital:
AXR according to Liverpool-Perth protocol
U&E, FBC
One month after EVAR
Arterial phase CTA
DUS
U&E, FBC, Clinical examination
Twelve months after EVAR and annually thereafter
DUS
AXR according to Liverpool-Perth protocol
U&E
Arterial phase CT, if the above modalities are undiagnostic orImaging costs have been calculated on the basis of 2010e11
NHS tariffs and converted to Euro (£1 Z V1.18).
All forms of aneurysm-related imaging performed during
the study period were reviewed. Patients who required
secondary interventions were identified from the database
and imaging reports and case-notes were reviewed.
General practitioners were contacted or hospital records
reviewed when patients died during follow-up, to identify
possible aneurysm-related mortality.
Surveillance Protocol
Before Aug 2005, post-EVAR surveillance was conducted
according to the EUROSTAR protocol or UK-EVAR trials
protocol, both requiring regular CTA. A modified protocol
(Table 1), involving annual DUS and AXR was instituted on
1st August 2005, with CTA performed only when problems
were identified or DUS was not diagnostic. CTA was trig-
gered by significant findings on AXR or DUS. These included
features of stent migration, DUS finding of a stent-graft
related endoleak, endoleak that cannot be satisfactorily
characterised as type 2, aneurysm enlargement, and
stenosis or kinking of iliac limbs. When satisfactory views of
the aneurysm could not be obtained on DUS due to tech-
nical reasons such as obesity, CTA was obtained. The early
practice of investigating all type 2 endoleaks with CTA was
changed later to CTA only when aneurysm expansion of at
least 5 mm is documented.
DUS was performed by vascular sonographers trained in
post-EVAR imaging and to a protocol. A Philips iU22 ultra-
sound scanner (Philips Healthcare, DA Best, Netherlands)
was used with an abdominal curved array probe (2e5 MHz).
The maximum aneurysm diameter and aneurysm neck
diameter were measured on grayscale images. The aneu-
rysm contents were assessed using colour Doppler to iden-
tify endoleaks. Endoleaks were also sought by identifying
and specifically interrogating echo-poor areas within the
thrombus. The endograft, distal external iliac and common
femoral arteries were imaged using colour flow and spectral
Doppler to ascertain patency and flow haemodynamics.
Antero-posterior and lateral AXR projections are per-
formed according to the Liverpool-Perth protocol,6 which
limits projectional inconsistencies from true migration.7
CTA were performed on a Siemens 128 Definition plus and
interpreted by an experienced specialist vascular radiolo-
gist. Single arterial-phase images were recorded from thesuggestive of a problem
T 0 12 24 36 48 
194 160 94 51 15 
Figure 1 KaplaneMeier curve showing cumulative freedom
from CTA.
Table 2 Reasons for CTA in 55 patients.
Patients
requiring
CTA
Sets of imaging
that required
CTA
Inadequate DUS 20 31
Abnormality identified
by either DUS or AXR
30 31
Other reason 7 8
Total 55a 70
a Two patients had two different indications for CTA.
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above the stent. Measures to counter contrast-induced
nephropathy were in place for CTA, which required intra-
venous prehydration when the estimated glomerular
filtration rate was <30 ml/min.
Results
Two hundred and sixty-two patients underwent standard
EVAR between 1st Aug 2005 and Apr 2009. Forty-four
patients followed-up at other hospitals and 24 who died
within one-year of EVAR (10 ischaemic heart disease, 5
malignancy, 5 gastrointestinal disease, 3 respiratory illness
and 1 cerebrovascular accident) were excluded from anal-
ysis. A total of 194 patients with a median age of 76 yr
(range 47e93), of whom 29 (15%) were female, were
followed-up for a median of 36 months (range 12e57) and
were included in the main analysis.
Thirteen patients (7%) had deviations to follow-up
protocol; one patient did not attend follow-up imaging at
year one, but attended in subsequent years and five had
delayed surveillance imaging. Three patients moved their
follow-up to other hospitals and only the surveillance at our
institution was included. Four patients (2%) were lost to
follow-up due to unrelated illnesses or declined follow-up.
Twenty-five patients who had imaging at year one, died
during the course of the study (13%). Causes of death were
malignancy (n Z 10), ischaemic heart disease (n Z 6),
respiratory illness (nZ 3), gastrointestinal disease (nZ 2),
cerebrovascular accident (nZ 2), and renal failure (nZ 1).
There was one aneurysm-related death from late rupture
while awaiting open conversion.
The remaining 194 patients underwent a total of 606 sets
of surveillance imaging; 194 sets at onemonth (AXR, DUS and
CTA) and 412 per protocol sets thereafter (AXR and DUS). Of
these 412 sets of modified protocol imaging, 70 led to CTA
(17%). The proportion of patients under surveillance referred
for CTA at 1, 2, 3, and 4- years was 19%, 18%, 12% and 17%
respectively. The utility of the modified surveillance
protocol was analysed as freedom from undergoing CTA by
KaplaneMeier analysis (Fig. 1),which demonstrated that 65%
of patients did not require CTA at four years follow-up.
The reasons for undertakingCTAon70 (17%) occasions in55
(28%) patients are presented in Table 2. DUS and/or AXR
revealed a problem in 31 (8%) sets of imaging (30 patients),
(DUS abnormalities in Table 3) of which 18 were confirmed by
subsequent CTA. Sixteen AXR showed migration; ten were
confirmed by CTA and seven required reintervention. Nine
endoleaks were shown by DUS; at CTA one type-1 was
confirmed, one refuted, 4 type-2 confirmed and 3 indetermi-
nate endoleaks were not seen. CTAwas performed for follow-
up of spinal osteomyelitis in one patient (two scans), to
monitor other aneurysms in one, for consideration of renal
transplant in one and as a baseline in four patients who had
missed scans at one month. None of these CTA showed any
EVAR-related abnormality.
Positive Predictive Value (PPV) of DUS and AXR
Arterial phase CTA is considered the gold standard against
which the PPV of the other imaging modalities wascalculated. The total number of patients in whom an
abnormality was identified by either duplex or AXR was 30,
of whom 18 had an abnormality confirmed giving a PPV for
the combination of duplex and AXR of 60%. Ten of the
twenty abnormalities found on duplex were confirmed by
CTA (PPV 50%). An abnormality was detected on AXR on
sixteen occasions and this was further investigated on 15
occasions by CT, confirming the finding in ten (PPV 67%).
Secondary Interventions
Nine patients required a secondary intervention within the
first year of EVAR. Two patients required intra-operative
femoral embolectomy. The other seven patients required
intervention for limb kinking/stenosis including one femo-
ralefemoral bypass and six angioplasty/stents.
Nine patients had a secondary intervention after one
year following EVAR, for a problem identified by the
modified surveillance protocol (Table 4). In addition, two
further patients (total 6%) were noted to have stent-graft
migration (on AXR) and conversion to open repair was
considered indicated. One patient did not have open
conversion as advanced colonic malignancy also was diag-
nosed during preoperative investigations and the other
patient suffered fatal rupture of the aneurysm before the
planned admission for conversion.
Table 3 DUS abnormalities.
Duplex
abnormality
Number CTA
confirmation
Intervention
required
Limb occlusion 2 2
Limb stenosis 2 1
Limb kink 4a 1b 3
Aneurysm
expansion
2 1
Endoleak 9 5 1 (type 1
endoleak
shown by DUS
and CTA)
Aortic
dissection
1 0
Total 20c 10
a One patient had an iliac stent without prior CT.
b CT did not confirm duplex, but the patient still had iliac
stent.
c Two patients had more than one type of abnormality
requiring CTA.
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Table 5 shows the number of duplex, AXR and CTA actually
performed and those that would have been performed
under the old surveillance protocol. Furthermore, 19 (10%)
patients had an eGFR of under 30 ml/min and would have
required overnight hospital admission for hydration for
renoprotection.
Radiation Dose
The radiation dose of a single phase CT abdomen and pelvis
has been estimated to be 15 mSv, though this would varyTable 4 Secondary interventions with imaging initiating CT.
Patient Problem
identified
Modified
surveillance
1 Persistent type 2
endoleak
Poor DUS views
2 Junctional stenosis DUS
3 Kinked graft DUS
4 Kinked graft DUS
5 Graft migration AXR
6 Limb dislocation AXR, poor
DUS views
7 Graft migration AXR
8 Graft migration AXR
9 Graft migration AXR and DUS
10 Graft migration
and type 1
endoleak
AXR and DUS
11 Graft angulation AXR and DUSwith type of scanner and patient size.8 Within this cohort of
patients the total population dose would have been
6180 mSv with the old protocol (involving annual CTA
surveillance). The modified protocol has reduced this pop-
ulation dose to 1065 mSv. The majority of patients under-
going surveillance with the modified protocol will avoid
exposure of 45 mSV at 3 years which is the equivalent dose
of 2250 chest radiographs.9Discussion
In the context of post-EVAR surveillance, DUS is a reliable
modality of imaging to determine aneurysm size, to identify
and characterise endoleak and to investigate haemody-
namics within the stent-graft. Plain radiography performed
according to protocol has the capacity to demonstrate
stent-graft migration and structural disintegration reliably.
A combination of DUS and AXR therefore has the potential
to reveal most of the information sought through surveil-
lance imaging. This provides an opportunity to reduce
reliance on arterial phase CTA. We have modified our
surveillance protocols with a view to make the best use of
DUS and AXR in surveillance and consequently reduce the
use of CTA and the purpose of this study was to report the
safety and benefits of this modification.
The main weakness of this study is the lack of
a comparator group that underwent surveillance according
to traditional protocol or the lack of gold standard imaging
at the time of every episode of surveillance imaging.
Therefore it is not possible to calculate the sensitivity or
specificity of the modified surveillance protocol, in
comparison to an alternative follow-up. This report should
be recognised as an observational study of clinical practice
from which it is possible to make certain observations.
In this series there were no instances of late aneurysm
rupture due to failure of surveillance. The patient whoCTA
findings
Procedure
Type 2 endoleak Embolisation
CTA not a significant
stenosis
Iliac angioplasty
CTA not a significant
stenosis
Iliac stent
CTA not performed Iliac stent
Migration on CTA Open revision
Migration on CTA Bridging stent
Migration on CTA Open revision
cancelled as liver mets
Migration on CTA Open revision
Migration on CTA Open revision
Migration on CTA Open revision planned,
but ruptured and died
before operation
No abnormality
on CTA
Stent
Table 5 The costs and savings of CTA using old and modified surveillance protocols after baseline images.
Image
type
Unit
costa
Old
protocol
Total costs Actual
numbers
Total actual
cost
Saving
AXR V35.71 412 V14,711.20 412 V14,711.20
Duplex V187.47 412 V77,326.24 412 V77,326.24
CTA V269.61 412 V111,077.84 71 V19,142.31
Total V492.79 V203,115.28 V111,179.75 V91,935.53
a 2010e2011 NHS tariff.
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at risk by the modified surveillance protocol. There were no
patients who presented with a symptomatic complication
before being identified by surveillance.
It is also important to acknowledge that the majority of
complications were picked up by DUS or AXR and only
infrequently by both. Therefore the complimentary nature
of these modalities should be recognised and neither on its
own can be suggested to be a substitute for CTA. The
combined PPV of duplex and AXR is modest at 60% which
confirms that overall, CTA is indispensable as an imaging
modality for surveillance. The CTA required to investigate
false positive results of DUS and/or AXR are more than
compensated by the overall reduction of CTA. It is also
appropriate to point out that DUS can be used to its full
potential only when the observers have appropriate expe-
rience and use good quality equipment. Similarly the
importance of understanding the plain AXR acquisition
protocol and adherence to it is important to minimise the
risk of erroneous interpretation.
DUS did not always yield diagnostic reports, usually due to
body habitus or bowel gas. In some of these patients, DUS did
in fact provide satisfactory images on subsequent occasions
and therefore one instance of un-diagnostic DUS does not
preclude one from modified surveillance altogether.
In our series, there were examples of significant abnor-
malities escaping detection on CTA. This is due to the lack
of direct haemodynamic information. There were two
patients in whom significant iliac limb kinking was detected
by DUS that prompted CTA for further investigation.
However, when CTA was unremarkable, the DUS findings
were considered worthy of further investigation resulting in
both the patients undergoing catheter angiography during
which significant stenoses with pressure gradients were
confirmed and treated by secondary intervention.
The main drivers for modifying the surveillance to one
based predominantly on AXR and DUS are reductions in
exposure to radiation and to iodinated intravascular contrast
medium. Patients who have had EVAR have had significant
radiation exposure in planning, performance and 1-month
CTA for their EVAR. These patients are in the 50e100 mSv
exposure group in whom significant increases in cancer risk
have been identified.10 Reducing exposure to ionising radi-
ation by limiting the number of CTAs performed will reduce
this risk. Intravenous contrast medium is an important
component of CTA, though has a significant risk itself. One
study of risk of contrast nephropathy showed an 11% inci-
dence of renal damage and 0.6% mortality rate following
contrast enhanced CT.11 This risk can be eliminated in most
patients with the modified surveillance program. Non-
contrast enhanced CT scan has the benefit of avoiding therisks of contrast medium and is a useful technique for
assessing stent-graft position, but cannot assess endoleak
and still requires radiation exposure.
In the cohort of patients within this series a saving of
over V91,935 has been made by avoiding CTA (V223 per
patient, per year). Our protocol included DUS prior to the
institution of the modified protocol so these savings are
genuine. For centres not already using DUS the savings will
be smaller, based on the difference in the price of DUS and
CTA. Additional savings are to be had from costs of CIN
prophylaxis including possible hospital admissions for
intravenous hydration and monitoring of renal function. In
addition no patient presented with EVAR-related compli-
cations, including aneurysm rupture which had not been
identified by the surveillance program.
Conclusions
Follow up after EVAR primarily based on DUS and AXR is
feasible and safe. This reduces the use of CTA substantially
with consequent reduction in exposure to ionising radiation
and intravascular contrast medium. This study also confirms
the complimentary nature of AXR and DUS for the purposes
of post-EVAR surveillance.
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